Brugafar SA
4.4 FTEBrugafar reported total assets of €1.18m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 4.4 full-time equivalents.
The score of Brugafar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6 % Total assets -21 % Headcount (avg FTE) +13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Brugafar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 24,902 € | ||||
| Equity | 490,074 € | ||||
| Cash | 214,068 € | ||||
| EBITDA | 104,956 € | ||||
| Total assets | €1.18m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Brugafar's financial analysis
- Solvency41.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Brugafar
Brugafar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0462.671.192
- VAT number
- BE0462671192
- Peppol
- Registered · 0208:0462671192 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 16 Feb 1998
- Registered office
- 8620 Nieuwpoort
- Size
- Micro · 4.4 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Brugafar (SA) has been based in Nieuwpoort since 1998, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 24,902 € and equity of 490,074 €; its revenue is not published. With 4.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 41.5%, below the median of its sector (44.2%).
Companies similar to Brugafar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Versteele Retail sale of pharmaceutical products Veurne · balance sheet €1.18m
- Pharmacie DU Baty Retail sale of pharmaceutical products Profondeville · balance sheet €1.18m
- Medigrex Retail sale of pharmaceutical products Wuustwezel · balance sheet €1.18m
- MPL Pharma Retail sale of pharmaceutical products Ciney · balance sheet €1.05m
- Apotheke Schunck Retail sale of pharmaceutical products Eupen · balance sheet €1.18m
- Pharmaphie SDW Retail sale of pharmaceutical products Ghent · balance sheet €1.19m
- Zellik Pharma Retail sale of pharmaceutical products Asse · balance sheet €1.25m
- Sanophar Retail sale of pharmaceutical products Menen · balance sheet €1.17m
Frequently asked questions about Brugafar
What is the revenue of Brugafar?
Brugafar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Brugafar?
In Belgium, the VAT number is the company number prefixed with BE: BE0462671192 for Brugafar, if the company is VAT-registered. Its company number (CBE) is 0462.671.192.
Where is the registered office of Brugafar?
According to the CBE register, the registered office of Brugafar is in 8620 Nieuwpoort.
What is the equity of Brugafar?
At the close of the 2025 financial year, the equity of Brugafar amounts to 490,074 €, a solvency of 41.5% of total assets.
How many people work at Brugafar?
4.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Brugafar?
The register lists 4 active mandates at Brugafar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Brugafar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →